Institution profile

医療法人 聡彩会 あつたモール総合クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01D2302009 +11

Location

Prefecture
Aichi
Address
名古屋市熱田区六野1-2-11 イオンモール熱田3階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • ヴィヴィアン特定認定再生医療等委員会
  • 再生医療細胞治療特定認定再生医療等委員会
  • 再生医療安全推進委員会 特定認定再生医療等委員会
  • +3

Public score

75.5/ 100

A · Review level
25.0 / 30
B · Technologies
29.5 / 35
C · Coverage
14.3 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 75.5
Public score →100

Registered technologies (12)

Stem cells (all sources) 4
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた肝障害の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
Adipose-derived stem cells 4
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた肝障害の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
NK and immune cells 8
Registered technologies · Japanese originalTechnology areasPlan classification
がんの治療、再発・転移予防、発がん予防のための自己免疫細胞を用いた免疫細胞療法(6種複合免疫療法)NK and immune cellsClass III
悪性腫瘍に対する自家樹状細胞ワクチン療法NK and immune cellsClass III
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)NK and immune cellsClass III
悪性腫瘍の予防に対する自家NK細胞療法NK and immune cellsClass III
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(皮下)NK and immune cellsClass III
αβT細胞療法NK and immune cellsClass III
NK細胞免疫監視強化療法(NK-IST療法:NK IMMUNE SURVEILLANCE THERAPY)NK and immune cellsClass III
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(点滴)NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Skin 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II

Certified committee for regenerative medicine

  • ヴィヴィアン特定認定再生医療等委員会
  • 再生医療細胞治療特定認定再生医療等委員会
  • 再生医療安全推進委員会 特定認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会
  • NPO法人抜苦ねっと認定再生医療等委員会
  • 同仁会認定再生医療等委員会

Public document number

  • 01D2302009
  • 03D2311005
  • 03D2311006
  • 03D2311007
  • 01D2601006
  • 01D2601007
  • 01D2601008
  • 01D2605001
  • 01D2310003
  • 01D2311003
  • 01D2311006
  • 01D2504009
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Class IIヴィヴィアン特定認定再生医療等委員会01D2302009
自己脂肪由来幹細胞を用いた肝障害の治療Class IIヴィヴィアン特定認定再生医療等委員会03D2311005
自己脂肪由来幹細胞を用いた変形性関節症の治療Class II再生医療細胞治療特定認定再生医療等委員会03D2311006
自己脂肪由来幹細胞を用いた慢性疼痛の治療Class II再生医療細胞治療特定認定再生医療等委員会03D2311007
αβT細胞療法Class III再生医療安全推進委員会 特定認定再生医療等委員会01D2601006
NK細胞免疫監視強化療法(NK-IST療法:NK IMMUNE SURVEILLANCE THERAPY)Class III再生医療安全推進委員会 特定認定再生医療等委員会01D2601007
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(点滴)Class III再生医療安全推進委員会 特定認定再生医療等委員会01D2601008
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(皮下)Class III再生医療安全推進委員会 特定認定再生医療等委員会01D2605001
悪性腫瘍の予防に対する自家NK細胞療法Class III医療法人清悠会 認定再生医療等委員会01D2310003
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)Class IIINPO法人抜苦ねっと認定再生医療等委員会01D2311003
悪性腫瘍に対する自家樹状細胞ワクチン療法Class IIINPO法人抜苦ねっと認定再生医療等委員会01D2311006
がんの治療、再発・転移予防、発がん予防のための自己免疫細胞を用いた免疫細胞療法(6種複合免疫療法)Class III同仁会認定再生医療等委員会01D2504009

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor